CAV1 and Miyoshi myopathy: Among them, CDH2 (N‐cadherin) is associated with poor prognosis of MM patients and contributes to the adhesion of MM cells to BMSCs.[9] Thus, CAV1 suppression likely reduces cell adhesion and drug resistance by decreasing surface N‐cadherin.